Dr Hemal Mehta

Dr Hemal Mehta

Medical Retinal Ophthalmologist MBBS MD(Cantab.) FRCOphth FRANZCO

Background

Dr Hemal Mehta is a macula disease specialist and cataract surgeon with over 15 years experience. 

He is at the forefront of retinal research globally and is involved in clinical trials of the latest therapies for macula disease. Dr Mehta is a Senior Researcher with the Fight Retinal Blindness! Registry at Sydney University, developing evidence-based guidelines to improve intravitreal injection treatment outcomes for diseases like wet age-related macular degeneration and diabetic macular oedema. He has over 50 peer-reviewed publications. More information is available at drhemalmehta.com.au/research/

Dr Mehta previously further specialised with medical retina and cataract surgery fellowships at Sydney Eye Hospital and Moorfields Eye Hospital. The clinical research during these fellowships contributed to his Doctorate of Medicine on ‘Novel endpoints in diabetic retinopathy clinical trials’ from Cambridge University. He was previously an Ophthalmology Consultant at Royal Free London NHS Foundation Trust running the intravitreal injection services, teaching cataract surgery and leading the retinal clinical trials unit.   

Dr Mehta is a retinal specialist on the Therapeutics Committee of the Royal Australian and New Zealand College of Ophthalmologists. He is a member of the Australian and New Zealand Society of Retinal Specialists and Australasian Society of Cataract and Refractive Surgeons. He has performed over 2000 cataract operations.

Hemal enjoys hiking, chess and spending time with his wife and two children. He is committed to delivering high-quality, evidence-based, and compassionate care for his patients. 

Related Publications

Scientific Journal Publications

Spooner KL, Fraser-Bell S, Hong T, Wong JG, Chang AA. Long-term outcomes of anti-VEGF treatment of retinal vein occlusion. Eye (Lond). 2021 Jun 11.

Read more
Scientific Journal Publications

Ogura Y, Jaffe GJ, Cheung CM, Kokame GT, Iida T, Takahashi K, Lee WK, Chang AA, Monés J, D’Souza D, Weissgerber G. Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK. British Journal of Ophthalmology. 2021 Jul 21.

Read more
Scientific Journal Publications

Jhaveri, C., Wykoff, C.C., Khanani, A.M., Eandi, C.M., Chang, A., Guruprasad, B., Gedif, K.A. and Singer, M., 2021. Early Residual Fluid-free Status and Long-term BCVA outcomes: A Treatment Agnostic, Post-hoc Analysis of Pooled HAWK and HARRIER Data. American Journal of Ophthalmology.

Read more
Scientific Journal Publications

Racic T, Chang A, Fernando N, Brandli A, Natoli R, Penfold P, Provis JM, Rutar M. Anti-inflammatory and neuroprotective properties of the corticosteroid fludrocortisone in retinal degeneration. Exp Eye Res. 2021 Sep 9:108765. doi: 10.1016/j.exer.2021.108765. Epub ahead of print. PMID: 34509498.

Read more

Our Affiliates